MedTrace Logo

Impact of Specialist Led Integrated Care in COPD

NCT03482700 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2019-10-28

No results posted yet for this study

Summary

This study will look at the impact of care delivery by a specialist respiratory doctor compared to general practitioners for patients with COPD in East Birmingham. The primary outcome will be to compare the rates of provision of guideline-based care in intervention and control practices.

Conditions

Interventions

BEHAVIORAL

Intervention Arm

The intervention group will have their usual annual COPD review performed by a specialist respiratory doctor at baseline and 12 months. The patients will receive care using our local COPD guidance which has been accepted by all local commissioning groups and secondary care organisations.

BEHAVIORAL

Control Arm

Usual standard of care

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Heart of England NHS Trust

    lead OTHER

Principal Investigators

  • Alice Turner, MD · Heart of England NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-06
Primary Completion
2019-06-03
Completion
2020-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482700 on ClinicalTrials.gov